|
MRPL37 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.881590E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.377800E-01 |
| Normal-vs-Stage2 |
3.707600E-02 |
| Normal-vs-Stage3 |
1.522370E-01 |
| Normal-vs-Stage4 |
4.460600E-01 |
| Stage1-vs-Stage2 |
5.364200E-02 |
| Stage1-vs-Stage3 |
2.213600E-01 |
| Stage1-vs-Stage4 |
5.968000E-01 |
| Stage2-vs-Stage3 |
2.411000E-01 |
| Stage2-vs-Stage4 |
2.123800E-01 |
| Stage3-vs-Stage4 |
7.311400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.877440E-01 |
| Normal-vs-AfricanAmerican |
3.887600E-01 |
| Normal-vs-Asian |
4.958200E-01 |
| Caucasian-vs-AfricanAmerican |
8.754000E-01 |
| Caucasian-vs-Asian |
9.097400E-01 |
| AfricanAmerican-vs-Asian |
8.330000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.534200E-01 |
| Normal-vs-Female |
1.442570E-01 |
| Male-vs-Female |
4.829200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.765800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.014000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.883900E-02 |
| Normal-vs-Age(81-100Yrs) |
3.152200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.337000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.013200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.272200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.335200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.264800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.922000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.165700E-02 |
| Classical-VS-Follicular |
5.352000E-01 |
| Classical-VS-Other |
2.296200E-01 |
| Classical-VS-Normal |
1.266570E-01 |
| Tall-VS-Follicular |
2.080400E-02 |
| Tall-VS-Other |
2.185900E-02 |
| Tall-VS-Normal |
1.115510E-03 |
| Follicular-VS-Other |
5.306800E-01 |
| Follicular-VS-Normal |
6.937000E-01 |
| Other-VS-Normal |
3.683000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.230400E-02 |
| Normal-vs-N1 |
6.908400E-02 |
| N0-vs-N1 |
1.124240E-03 |
|
|
